Current price is less than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Not a good time to invest, stock is in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
5 days ago•Business Standard
5 days ago•Business Standard
Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download
Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download
Final • Div/Share: ₹ 0.5
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value